NIH Study Aims to Identify Promising COVID-19 Treatments for Larger Clinical Trials
October 13, 2020 -- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Clinical Trials | COVID-19 | Infectious Diseases | National Institutes of Health (NIH) | Pharmaceuticals | Study